转换全髋关节置换术与初次全髋关节置换术达到最小临床重要差异率的配对比较
回顾性病例对照研究将148例转换全髋关节置换术(cTHA)与296例配对初次全髋关节置换术(THA)比较,发现cTHA患者达到初次THA特异性1年患者报告结局指标最小临床重要差异(MCID)的比值比降低,cTHA特异性1年MCID分别为+10.71和+4.68。
要点
- 转换全髋关节置换术患者达到初次全髋关节置换术特异性1年HOOS-JR和PROMIS PF SF-10a最小临床重要差异的比值比显著降低。
- 不足60%的转换全髋关节置换术患者达到最小临床重要差异。
- 转换全髋关节置换术特异性1年HOOS-JR和PROMIS PF SF-10a的最小临床重要差异分别为+10.71和+4.68。
核心结论
- 转换全髋关节置换术与初次全髋关节置换术属于同一诊断相关组,但转换全髋关节置换术患者达到初次全髋关节置换术特异性1年患者报告结局指标最小临床重要差异的比值比降低。
研究设计与样本
- 回顾性病例对照研究,纳入148例转换全髋关节置换术病例,按1:2匹配296例初次全髋关节置换术患者。
- 采用先前定义的初次全髋关节置换术2项患者报告结局指标的锚定值比较转换全髋关节置换术与初次全髋关节置换术,并通过分布法计算转换全髋关节置换术特异性2项患者报告结局指标的最小临床重要差异值。
- 通过多因素logistic回归分析达到患者报告结局指标最小临床重要差异的预测因素。
主要发现
- 转换全髋关节置换术患者达到初次全髋关节置换术特异性1年髋关节功能障碍与骨关节炎结局评分-关节置换版(HOOS-JR)最小临床重要差异的比值比为0.319(95%置信区间:0.182-0.560,P < .001)。
- 转换全髋关节置换术患者达到初次全髋关节置换术特异性1年患者报告结局测量信息系统身体功能简表10a(PROMIS PF SF-10a)最小临床重要差异的比值比为0.531(95%置信区间:0.313-0.900,P = .019)。
- 不足60%的转换全髋关节置换术患者达到最小临床重要差异。
关键数值与推荐
- 转换全髋关节置换术特异性1年HOOS-JR最小临床重要差异为+10.71。
- 转换全髋关节置换术特异性1年PROMIS PF SF-10a最小临床重要差异为+4.68。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据等级为III级,回顾性比较研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient-reported outcome measures (PROMs) are often lower following conversion total hip arthroplasty (cTHA) compared to matched primary total hip arthroplasty (THA) controls. However, the minimal clinically important differences (MCIDs) for any PROMs are yet to be analyzed for cTHA. This study aimed to (1) determine if patients undergoing cTHA achieve primary THA-specific 1-year PROM MCIDs at comparable rates to matched controls undergoing primary THA and (2) establish 1-year MCID values for specific PROMs following cTHA. METHODS: A retrospective case-control study was conducted using 148 cases of cTHA which were matched 1:2 to 296 primary THA patients. Previously defined anchor values for 2 PROM measures in primary THA were used to compare cTHA to primary THA, while novel cTHA-specific MCID values for 2 PROMs were calculated through a distribution method. Predictors of achieving the MCID of PROMs were analyzed through multivariate logistic regressions. RESULTS: Conversion THA was associated with decreased odds of achieving the primary THA-specific 1-year Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement PROM (Odds Ratio: 0.319, 95% Confidence Interval: 0.182-0.560, P < .001) and Patient Reported Outcomes Measurement Information System Physical Function Short-Form-10a PROM (Odds Ratio: 0.531, 95% Confidence Interval: 0.313-0.900, P = .019) MCIDs in reference to matched primary THA patients. Less than 60% of cTHA patients achieved an MCID. The 1-year MCID of the Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement and Patient Reported Outcomes Measurement Information System Physical Function Short-Form-10a specific to cTHA were +10.71 and +4.68, respectively. CONCLUSION: While cTHA is within the same diagnosis-related group as primary THA, patients undergoing cTHA have decreased odds of achieving 1-year MCIDs of primary THA-specific PROMs. LEVEL OF EVIDENCE: Level III, retrospective comparative study.
引用
- Humphrey TJ, Salimy MS, Duvvuri P, et al. A Matched Comparison of the Rates of Achieving the Minimal Clinically Important Difference Following Conversion and Primary Total Hip Arthroplasty. J Arthroplasty. 2023. PMID: 36931363. doi:10.1016/j.arth.2023.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。